Arabic Arabic English English French French German German
dark

Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics’ RheOx™ System for Chronic Bronchitis

Gala Therapeutics, Inc. today announced new data from multiple clinical studies that demonstrate improvements in chronic bronchitis symptoms after patients received bronchial rheoplasty therapy using Gala’s first-of-its kind, endoscopic RheOx ™  system. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Departure of Founder and CEO Heightens Uncertainty for Galapagos

Next Post

Medivir receives regulatory approval from MHRA for phase 1/2a combination study with MIV-818

Related Posts
Total
0
Share